Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-05-059898
Filing Date
2005-03-24
Accepted
2005-03-24 17:03:39
Documents
7
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d10ka.htm 10-K/A 1200915
2 SCIENTIFIC ADVISORY AGREEMENT BY AND BETWEEN THE COMPANY AND ANDREW WOLFF dex1052.htm EX-10.52 34610
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2264
4 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 8902
5 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 8883
6 CERTIFICATION OF CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 2843
7 CERTIFICATION OF CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 2814
  Complete submission text file 0001193125-05-059898.txt   1263653
Mailing Address 3172 PORTER DRIVE PALO ALTO CA 94304
Business Address 3172 PORTER DR PALO ALTO CA 94304 6503848500
CV THERAPEUTICS INC (Filer) CIK: 0000921506 (see all company filings)

EIN.: 431570294 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-21643 | Film No.: 05702626
SIC: 2836 Biological Products, (No Diagnostic Substances)